HomeANVS • NYSE
add
Annovis Bio Inc
Previous close
$5.20
Day range
$4.76 - $5.10
Year range
$4.21 - $20.00
Market cap
67.47M USD
Avg Volume
445.32K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.39M | -70.48% |
Net income | -12.64M | 14.12% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.64M | 98.85% |
Total assets | 14.36M | 40.48% |
Total liabilities | 7.30M | 104.71% |
Total equity | 7.06M | — |
Shares outstanding | 13.80M | — |
Price to book | 9.81 | — |
Return on assets | -113.04% | — |
Return on capital | -412.93% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -12.64M | 14.12% |
Cash from operations | -3.20M | 65.83% |
Cash from investing | — | — |
Cash from financing | 11.84M | — |
Net change in cash | 8.64M | 192.20% |
Free cash flow | -1.69M | 57.10% |
About
Founded
2008
Headquarters
Website
Employees
6
